MediLink Therapeutics Ltd. is exploring a licensing partnership to develop an antibody-drug conjugate with a global pharmaceutical company, according to people familiar with the situation ...

The clinical trial is being sponsored by development partner Suzhou MediLink. The study is evaluating the antibody drug conjugate, or ADC, in the treatment of advanced or metastatic EGFR-mutated ...

CheckUp Health, a UK-based AI-powered healthcare platform founded by entrepreneur Fungai Ndemera, has been shortlisted as a ...

Medilink North of England, a professional membership association and specialist consultancy for the life sciences sector has taken steps to tackle this issue with two recent investment events ...